POSC41 Cost-Effectiveness Analysis of Remdesivir for the Treatment of COVID-19 Hospitalized Adults in Mexico

por Ponce-de-León, A, Azamar-Alonso, A, Silva-Sanchez, F, Chirino-Sprung, R, Dominguez-Esquivel, V, Rajme-López, S
Publicado 2022

POS-869 The early Urinary sediment performance in the hospitalization in patients with COVID-19 and the Nephrology early intervention

por Rizo Topete MD, L., Arteaga-Müller, G., Guerrero, E., Camacho, A., Perez, E., Esquivel, V., Enriquez, V., Aguilar, G., Mata, L., Rangel, L.
Publicado 2022